1. Home
  2. LIXT vs QCLS Comparison

LIXT vs QCLS Comparison

Compare LIXT & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

N/A

Current Price

$2.50

Market Cap

25.3M

Sector

Health Care

ML Signal

N/A

QCLS

Q/C Technologies Inc.

N/A

Current Price

$4.05

Market Cap

27.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LIXT
QCLS
Founded
2005
2014
Country
United States
United States
Employees
4
2
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.3M
27.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIXT
QCLS
Price
$2.50
$4.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
43.5K
836.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$2.50
52 Week High
$6.09
$8.17

Technical Indicators

Market Signals
Indicator
LIXT
QCLS
Relative Strength Index (RSI) 30.14 51.70
Support Level $2.45 $4.00
Resistance Level $4.45 $4.57
Average True Range (ATR) 0.22 0.38
MACD -0.03 0.07
Stochastic Oscillator 0.13 42.77

Price Performance

Historical Comparison
LIXT
QCLS

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About QCLS Q/C Technologies Inc.

Q/C Technologies Inc is engaged in building blockchain infrastructure that is faster and more energy-efficient. The company uses laser-based processors inspired by quantum technology that can solve complex problems at the speed of light. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

Share on Social Networks: